Mina Kim
2018
In 2018, Mina Kim earned a total compensation of $3.4M as Former SVP, Corporate Strategy and General Counsel at Atara Biotherapeutics.
Compensation breakdown
| Bonus | $101,730 |
|---|---|
| Option Awards | $1,485,365 |
| Salary | $266,827 |
| Stock Awards | $1,530,000 |
| Other | $504 |
| Total | $3,384,425 |
Kim received $1.5M in stock awards, accounting for 45% of the total pay in 2018.
Kim also received $101.7K in bonus, $1.5M in option awards, $266.8K in salary and $504 in other compensation.
Rankings
In 2018, Mina Kim's compensation ranked 3,377th out of 14,244 executives tracked by ExecPay. In other words, Kim earned more than 76.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,377 out of 14,244 | 76th |
Division Manufacturing | 1,247 out of 5,759 | 78th |
Major group Chemicals And Allied Products | 436 out of 2,122 | 80th |
Industry group Drugs | 359 out of 1,811 | 80th |
Industry Biological Products, Except Diagnostic Substances | 77 out of 339 | 77th |
Source: SEC filing on April 22, 2020.
Kim's colleagues
We found four more compensation records of executives who worked with Mina Kim at Atara Biotherapeutics in 2018.
2018
Isaac Ciechanover
Atara Biotherapeutics
Chief Executive Officer
2018
Dietmar Berger
Atara Biotherapeutics
Former Global Head of Research & Development
2018
Utpal Koppikar
Atara Biotherapeutics
Chief Financial Officer
2018
Joseph Newell
Atara Biotherapeutics